Yi Zhang

TL;DR: T cell counts are reduced significantly in COVID-19 patients, and the surviving T cells appear functionally exhausted, and non-ICU patients with total T cells counts lower than 800/μL may still require urgent intervention, even in the immediate absence of more severe symptoms.

TL;DR: This paper focuses on three officially approved TKIs for HER2 breast cancer, namely, lapatinib, neratinib and pyrotinib, and systematically reviews the mechanism, safety, efficacy and resistance of these TK is.

TL;DR: Wang et al. as mentioned in this paper retrospectively reviewed the clinical and immunological data from 18 fatal coronavirus disease 2019 (COVID-19) cases, results showed that these patients had severe lymphocytopenia, together with high serum levels of inflammatory cytokines (IL-6, IL-8 and IL-10), and elevation of many other mediators in routine laboratory tests, including C-reactive protein, lactate dehydrogenase, α-hydroxybutyrate dehydrogenase and natriuretic peptide type B.

TL;DR: It can be concluded that potentially functional MTHFR C677T polymorphism may play a low penetrance role in the development of breast cancer.

TL;DR: Evidence is provided supporting a significantly positive association between plasma prolactin levels and the risk of breast cancer among the patients who were postmenopausal, ER+/PR+ or in situ and invasive carcinoma.